Trasylol Pulled From Worldwide Market. Nov. 5, 2007 (HealthDay News) Bayer AG suspended worldwide sales of Trasylol, a clotting drug using during heart surgery to prevent bleeding, on Monday following a request from the U.S. Food and Drug Administration to remove the drug from the American market for safety reasons.[ See ]. Image from Yahoo.news.
Read more: related news.

CLOT DRUG EYED IN 235 DEATHS: FDA.New York Post, November 18, 2007. The Food and Drug Administration has tallied at least 235 reports of deaths linked to the blood-clotting drug Trasylol, officials told The Post. The FDA received 235 reports "that noted death in patients who received Trasylol" to control bleeding during heart-bypass surgery from 1993, when the drug was approved, through February 2006, said agency spokeswoman Peper Long. [ See ]